Thrombocytopenia: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
No edit summary |
||
Line 13: | Line 13: | ||
{{Thrombocytopenia}} | {{Thrombocytopenia}} | ||
{{CMG}}, | {{CMG}}, {{AE}} {{FZ}} | ||
{{SK}} Congenital amegakaryocytic thrombocytopenia, CAMT | {{SK}} Congenital amegakaryocytic thrombocytopenia, CAMT | ||
Revision as of 14:39, 5 July 2018
<figure-inline></figure-inline> | Resident Survival Guide |
For patient information click here
Thrombocytopenia | |
Marked thrombocytopenia and fragmented red blood cells. Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology |
Thrombocytopenia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Thrombocytopenia On the Web |
American Roentgen Ray Society Images of Thrombocytopenia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Farbod Zahedi Tajrishi, M.D. Synonyms and keywords: Congenital amegakaryocytic thrombocytopenia, CAMT
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Thrombocytopenia from other Diseases
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies